Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial-Reference-Cited by-同舟云学术

Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial

Published:2016-05-23 Issue:5 Volume:63 Page:634-641
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clin Infect Dis.

Author:

Colgate E. Ross,Haque Rashidul,Dickson Dorothy M.,Carmolli Marya P.,Mychaleckyj Josyf C.,Nayak Uma,Qadri Firdausi,Alam Masud,Walsh Mary Claire,Diehl Sean A.,Zaman K.,Petri William A.,Kirkpatrick Beth D.

Funder

Bill & Melinda Gates Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/63/5/634/6713630/ciw346.pdf

Reference30 articles.

1. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis

2. Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

3. Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine